Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity

Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity

Abstract Hypertension is a recognized comorbidity for COVID-19. The association of antihypertensive medications with outcomes in patients with hypertension is not fully described. However, angiotensin-converting enzyme 2 (ACE2), responsible for host entry of the novel coronavirus (SARS-CoV-2) leadin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Majid Jaberi-Douraki, Emma Meyer, Jim Riviere, Nuwan Indika Millagaha Gedara, Jessica Kawakami, Gerald J. Wyckoff, Xuan Xu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/88722c0702ca410cafac6d604c2cd4d1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares